Aetion, FDA partner oncology on real-world data

AssociationA startup focused on real-world evidence in healthcare announced a five-year research collaboration with the FDA. Oncology Center of Excellence (OCE).

OCE will use Aetion’s evidence platform to find and analyze real-world data sources that can be used for research on cancer prevention, clinical care, diagnosis and treatment.

The collaboration will examine real-world endpoints, measure health care disparities and evaluate causal assessment methods. This research will continue till 2027.

“We are partnering with the FDA’s Oncology Center of Excellence to advance the application of real-world evidence and to better serve vulnerable and underrepresented populations,” Carolyn Magal, CEO of Aetion, said in a statement. Proud of the partnership.” “Our collaboration furthers our mission to understand which treatments work for which patients and brings us closer to achieving health equity among cancer patients.”

A big trend

Since its founding in 2013, the New York-based health tech company has made numerous investments.

In 2021, Aetion scored. $110 million in Series C fundingBringing the company’s total revenue to $212 million. The funding round comes less than a year after the company shut down $19 million Series B extension round.

In 2019, Sanofi Integrates its real-world data platform with Aetion’s evidence platform. Sanofi’s real-world data platform, DARWIN, provided de-identified patient data that Aetion’s Evidence Platform will analyze for insights into drug effectiveness, safety and value.

During the height of the pandemic in 2020, Aetion partnered with a healthcare data platform. Health Verity Launching tools to help biopharma companies and regulators find treatments for COVID-19

In December, Aetion announced to the FDA. Office of Data Analytics and Research Extending his contract till 2023, Initially signed in 2020., to examine real-world data on COVID-19 medical countermeasures. Aetion will expand its work to assess data standardization in the context of COVID-19.

#Aetion #FDA #partner #oncology #realworld #data

Leave a Reply

Your email address will not be published. Required fields are marked *